UNSPSC 51272006: Thiopental sodium

This classification denotes a barbiturate and anesthetic agent with the molecular formula C11H17N2O2S.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 49Y44QZL70, chemically known as 4,6(1h,5h)-pyrimidinedione, 5-ethyldihydro-5-(1-methylbutyl)-2-thioxo-, monosodium salt but more generally known as thiopental sodium, which bears US NIH Compound Identifier 3000714. European Medicines Agency schedules Thiopental sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10981MIG.

UNSPSC 51272006 Thiopental sodium is a Commodity code that does not reflect the actual work state and local governments are soliciting under it. Recent opportunities posted to this code involve naloxone procurement, direct-to-manufacturer prescription programs, and generic multi-source pharmaceuticals and OTC products — none of which are thiopental sodium. The code shows a mismatch between its nominal scope and current buying activity, suggesting either a systematic tagging error in the underlying procurement system or that this code is being used as a catch-all for pharmaceutical procurement when more specific commodity codes are unavailable.

State and local issuing bodies soliciting under the code span county health departments, state health and human services commissions, and multi-state cooperative purchasing alliances. Seminole County, Florida issued an IFB on June 30, 2026 for naloxone and drug deactivation systems with a response deadline of July 26, 2023 (with quarterly delivery requirements); the Texas Health and Human Services Commission posted an RFI on April 3, 2026 to explore direct-to-manufacturer prescription program capabilities; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP on January 20, 2026 for generic multi-source pharmaceuticals and OTC products with a response deadline of March 26, 2026, with awards effective July 1, 2026 across participating state and local facilities including Oregon. The geographic spread includes Florida, Texas, Minnesota, and Oregon. Without confirmed recent activity specifically for thiopental sodium, this code should be monitored for potential system-level retag corrections or reserved for future pharmaceutical procurement alignment.